Filter

Refine by date

—

Refine by collections

  • Print
  • Save

Search Results

You are looking at 1 - 4 of 4 items for :

Clear All
Tayyab S. Khan Division of Endocrinology and Metabolism, McMaster University, Hamilton, Ontario, Canada

Search for other papers by Tayyab S. Khan in
Google Scholar
PubMed Close
,
Esha Sharma LMC Diabetes and Endocrinology, Brampton, Ontario, Canada

Search for other papers by Esha Sharma in
Google Scholar
PubMed Close
,
Baldev Singh LMC Diabetes and Endocrinology, Brampton, Ontario, Canada

Search for other papers by Baldev Singh in
Google Scholar
PubMed Close
,
Bikram Jammu LMC Diabetes and Endocrinology, Brampton, Ontario, Canada

Search for other papers by Bikram Jammu in
Google Scholar
PubMed Close
,
Amarinder Chadha LMC Diabetes and Endocrinology, Brampton, Ontario, Canada

Search for other papers by Amarinder Chadha in
Google Scholar
PubMed Close
,
Divya Markanday LMC Diabetes and Endocrinology, Brampton, Ontario, Canada

Search for other papers by Divya Markanday in
Google Scholar
PubMed Close
,
Yan Yan Wu Office of Public Health Studies, University of Hawai’i at Manoa, Honolulu, Hawaii, USA

Search for other papers by Yan Yan Wu in
Google Scholar
PubMed Close
, and
Harpreet S. Bajaj LMC Diabetes and Endocrinology, Brampton, Ontario, Canada
Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada

Search for other papers by Harpreet S. Bajaj in
Google Scholar
PubMed Close

cytology results were available for 547 patients, who comprised our study cohort. Of these, 450 (82.2%) were female, with a mean age of 53.6 years. Forty-six patients were taking aspirin while 1 was on warfarin at the time of FNAB, adding up to a combined

Article Type:
Research Article
DOI:
https://doi.org/10.1159/000488451
Volume/Issue:
Volume 7: Issue 3
Free access
Yaser Jbara Boonshoft School of Medicine, Wright State University, Dayton, Ohio, USA

Search for other papers by Yaser Jbara in
Google Scholar
PubMed Close
and
Dean Bricker Boonshoft School of Medicine, Wright State University, Dayton, Ohio, USA

Search for other papers by Dean Bricker in
Google Scholar
PubMed Close

therapy) had been withdrawn 3 weeks previously in anticipation of adjuvant radioiodine ( 131 I) therapy. His medication included the following: aspirin 325 mg daily; atenolol 50 mg daily; atorvastatin 40 mg daily; clopidogrel 75 mg daily; insulin

Article Type:
Case Report
DOI:
https://doi.org/10.1159/000371548
Volume/Issue:
Volume 4: Issue 1
Free access
L. Leenhardt Department of Nuclear Medicine, Pitié Salpêtrière Hospital, Cancer Institute, Pierre et Marie Curie University, Paris, France

Search for other papers by L. Leenhardt in
Google Scholar
PubMed Close
,
M.F. Erdogan Department of Endocrinology and Metabolism, University of Ankara School of Medicine, İbni Sina Hastanesi, Ankara, Turkey

Search for other papers by M.F. Erdogan in
Google Scholar
PubMed Close
,
L. Hegedus Department of Endocrinology and Metabolism, Odense University Hospital, Odense, Denmark

Search for other papers by L. Hegedus in
Google Scholar
PubMed Close
,
S.J. Mandel Division of Endocrinology, Diabetes and Metabolism, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pa., USA

Search for other papers by S.J. Mandel in
Google Scholar
PubMed Close
,
R. Paschke Department of Endocrinology, University of Leipzig, Leipzig, Germany

Search for other papers by R. Paschke in
Google Scholar
PubMed Close
,
T. Rago Endocrine Unit 1, Department of Internal Medicine, Ospedale Cisanello, University of Pisa, Pisa, Italy

Search for other papers by T. Rago in
Google Scholar
PubMed Close
, and
G. Russ Department of Nuclear Medicine, Pitié Salpêtrière Hospital, Cancer Institute, Pierre et Marie Curie University, Paris, France

Search for other papers by G. Russ in
Google Scholar
PubMed Close

on bleeding complications do not exist for LN FNA. The authors suggest that for patients taking warfarin the INR be <2.5 or <3 if medically acceptable. Antiaggregant drugs, including aspirin, can be maintained. Thyroglobulin and Calcitonin in situ

Article Type:
Guideline
DOI:
https://doi.org/10.1159/000354537
Volume/Issue:
Volume 2: Issue 3
Free access
Georgios Kostopoulos Department of Endocrinology and Metabolism, Ippokratio General Hospital of Thessaloniki, Greece

Search for other papers by Georgios Kostopoulos in
Google Scholar
PubMed Close
and
Grigoris Effraimidis Department of Endocrinology and Metabolic Diseases, Larissa University Hospital, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece

Search for other papers by Grigoris Effraimidis in
Google Scholar
PubMed Close

, atrial fibrillation; aHR, adjusted hazard ratio; AS, aspirin; CVD, cardiovascular disease; DM, diabetes mellitus; EU, euthyroid; F, female; FU, follow-up; HR, hazard ratio; HT, hyperthyroidism; HTN, hypertension; IR, incidence rate; N/A, not available

Article Type:
Review Article
Collections:
Hyperthyroidism and thyrotoxicosis
DOI:
https://doi.org/10.1530/ETJ-23-0254
Volume/Issue:
Volume 13: Issue 2
Open access